Panelists discuss how integrating both tissue and liquid genomic testing at diagnosis and progression improves detection of tumor heterogeneity and informs personalized treatment decisions in ...
Dr. Michael Chernew introduces the panelists and this month's topic: Accountable Care Organizations (ACOs). Panel Moderator, Dr. Michael Chernew, gives a brief introduction on the panel’s topic, ...
The program opens with panelist introductions and an overview of ciltacabtagene autoleucel (ciltacel), a BCMA-directed autologous CAR T-cell therapy given as a single infusion and approved for adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results